Clemastine fumarate syrup

Company
Morton Grove Pharmaceuticals

Approval Status
Approved March 1998

Treatment for
allergic rhinitis

Areas
Immune System , Respiratory

Clemastine Fumarate Syrup 0.5 mg/5 ml, a generic version of Novartis' Tavist Syrup, has been approved for the treatment of allergic rhinitis.

Clemastine_fumarate_syrup Drug Information

The Clemastine_fumarate_syrup drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top